JOYS MILLER: Open Payments
NPI 1063844611 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,094 in 113 payments from 33 companies in 2025. Trend: 2023 $1,402 · 2024 $1,605 · 2025 $2,094
Food & beverage: $2,094
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 19 | $259 |
| ABBVIE INC. | 18 | $241 |
| Lilly USA, LLC | 7 | $202 |
| Axsome Therapeutics, Inc. | 10 | $189 |
| Novartis Pharmaceuticals Corporation | 6 | $114 |
| Otsuka America Pharmaceutical, Inc. | 5 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $96 |
| Novo Nordisk Inc | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $79 |
| GlaxoSmithKline, LLC. | 3 | $73 |
Products named: ELIQUIS, NURTEC ODT, LEQVIO, REXULTI, Sunosi, UBRELVY, CAPLYTA, ZEPBOUND.
Industry payments across VA — which companies pay providers there.
